Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$40.35 – $43.46
76% from low
Sector
Asset Management - Bonds
Exchange
ARCX
ETF
This iShares J.P. Morgan exchange-traded fund (ETF) is engineered to mirror the investment performance of an underlying index. This index is specifically composed of government bonds originating from developing economies, with the key characteristic that these bonds are issued in the native currencies of those nations.
www.ishares.com/us/products/239528/ishares-emerging-markets-local-currency-bond-etfNo one on the platform currently holds LEMB.
No tracked institution reports a position in LEMB as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-19 | $1.0153 | 2025-12-24 |
| 2023-12-14 | $0.4916 | 2023-12-20 |
No one on the platform has traded LEMB yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| LEMBiShares J.P. Morgan EM Local Currency Bond ETF | $42.72 | -0.00% | $718M | — |
| CEMBiShares J.P. Morgan EM Corporate Bond ETF | $44.66 | +0.06% | $394M | — |
| EEMSiShares MSCI Emerging Markets Small-Cap ETF | $74.42 | -0.83% | $395M | — |
| EMHYiShares J.P. Morgan EM High Yield Bond ETF | $39.56 | -0.15% | $600M | — |
| EWQiShares MSCI France ETF | $44.22 | -0.65% | $359M | — |
| GVIPGoldman Sachs Hedge Industry VIP ETF | $166.75 | -1.00% | $592M | — |
| HYBBiShares BB Rated Corporate Bond ETF | $45.86 | -0.07% | $426M | — |
Source: Financial Modeling Prep · peers by sector/industry
This iShares J.P. Morgan exchange-traded fund (ETF) is engineered to mirror the investment performance of an underlying index. This index is specifically composed of government bonds originating from developing economies, with the key characteristic that these bonds are issued in the native currencies of those nations.
No constituent disclosure available for this fund yet.
$INMB $LEMB $BIIB Let's go InmuneBio!! https://claude.ai/public/artifacts/3dd6649c-e7bf-4f60-9771-28a79622d962 INMB INMB INMB
View on StockTwits ↗$INMB Massive Paradigm Shift in Alzheimer's! The new Cochrane Review (CD016297) just dealt a devastating blow to the anti-amyloid hypothesis. 🚫 Gold-standard data from 42 trials shows that drugs like $LEMB and $BIIB clear plaque but fail to deliver meaningful cognitive benefits, while carrying serious safety risks like brain swelling (ARIA). 🤯 The market narrative is crumbling. Enter $INMB. Their lead asset, XPro™, targets neuroinflammation (soluble TNF), not amyloid. Cochrane's expert recommendation is clear: "Future research... should focus on other treatments." 💡 INmune Bio is the necessary evolution that Cochrane is inadvertently calling for. Structurally de-risked and perfectly positioned with XPro™ moving into pivotal trials with a biomarker-enriched design. Time to look beyond the failed amyloid funnel-vision. Check out my full strategic analysis in the graphic below! 🚀 #Alzheimers #Biotech #Investing #Neuroscience #TheNewNarrative https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016297/full?highlightAbstract=alzheimer%7Calzheimer%27s%7Calzheim
View on StockTwits ↗$LEMB Current Stock Price: $42.38 Contracts to trade: $47.0 LEMB Feb 20 2026 Call Entry: $0.05 Exit: $0.07 ROI: 53% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗4/4: JPMorgan cuts emerging‑market FX view to market weight on overcrowding after year‑long rally | View: JPMorgan’s downgrade from overweight to market weight highlights overcrowded EM FX positioning, raising near‑term… $EEM $EMLC $LEMB $UUP
View on StockTwits ↗In the last month $LEMB has a been trading in a tight range between 35.96 and 36.86. https://www.chartmill.com/stock/quote/LEMB/technical-analysis?key=ff99ed94-5af8-40d0-8df1-5e78e6e31e41&utm_source=TA&utm_medium=stocktwits&utm_campaign=TA&utm_content=LEMB
View on StockTwits ↗$LEMB may break out. Our analyzer suggests a buy stop @37.15 with a stop @36.86 as a possible low risk setup.. https://www.chartmill.com/stock/quote/LEMB/technical-analysis?key=ff99ed94-5af8-40d0-8df1-5e78e6e31e41&utm_source=stocktwits&utm_medium=TA&utm_content=LEMB&utm_campaign=social_tracking
View on StockTwits ↗$LEMB - IShares JP maximum pain price is slips to -1.0 https://www.macroaxis.com/stock-options/LEMB/IShares-JP-Morgan?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗Emerging Markets Presents Healthy Fundamentals $EBND $ELD $LEMB https://talkmarkets.com/content/bonds/emerging-markets-presents-healthy-fundamentals?post=391792
View on StockTwits ↗$LEMB - Maximum pain price builds up to -1.0 for IShares JP https://www.macroaxis.com/stock-options/LEMB/IShares-JP-Morgan?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗$LEMB - Option Volatility signal: IShares JP pin risk is slipping https://www.macroaxis.com/stock-options/LEMB/IShares-JP-Morgan?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗$LEMB: The long and short term trends are both positive. This is looking good! https://www.chartmill.com/stock/analyzer/stock/LEMB?key=ff99ed94-5af8-40d0-8df1-5e78e6e31e41&utm_source=stocktwits&utm_medium=TA&utm_content=LEMB&utm_campaign=social_tracking
View on StockTwits ↗Whitcomb & Hess Inc.,has filed Form 13F for Q4 2022.Opened NEW positions in $CVX $LEMB $MUB $VGIT $VIOO
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.